+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Agenus Inc - logo

Agenus is an immuno-oncology company that focuses on the discovery and development of treatments that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates. It is also developing Prophage, a heat shock protein-based autologous vaccine. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 3237 Pages
  • Global
From
Asia Pacific Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030

  • Report
  • December 2023
  • 138 Pages
  • Asia Pacific
From
North America Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030

  • Report
  • December 2023
  • 126 Pages
  • North America
From
Europe Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030

  • Report
  • December 2023
  • 136 Pages
  • Europe
From
LAMEA Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030

  • Report
  • December 2023
  • 137 Pages
  • Middle East, Africa
From
Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2019 - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) - Pipeline Review, H1 2019

  • Drug Pipelines
  • March 2019
  • 62 Pages
  • Global
From
Vaccine Particulate Adjuvant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Vaccine Particulate Adjuvant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 104 Pages
  • Global
From
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 2271 Pages
  • Global
From
Vaccine Adjuvants Market by Application and Geography - Forecast and Analysis 2020-2024 - Product Thumbnail Image

Vaccine Adjuvants Market by Application and Geography - Forecast and Analysis 2020-2024

  • Report
  • November 2019
  • 153 Pages
  • Global
From
Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1036 Pages
  • Global
From
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 1663 Pages
  • Global
From
Precision Immuno-Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Precision Immuno-Oncology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 178 Pages
  • Global
From
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 1699 Pages
  • Global
From
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
NK Cell therapies - Pipeline Insight, 2024 - Product Thumbnail Image

NK Cell therapies - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2024 - Product Thumbnail Image

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
TIGIT inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

TIGIT inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
4-1BB receptor Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

4-1BB receptor Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
CTLA-4 inhibitors- Competitive landscape, 2023 - Product Thumbnail Image

CTLA-4 inhibitors- Competitive landscape, 2023

  • Report
  • May 2023
  • 220 Pages
  • Global
From
Loading Indicator